miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2
- 24 April 2018
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 297 (6) , 1539-1548
Abstract
This study aimed to investigate the effect of miR-101-3p on autophagy in endometrial carcinoma (EC) cells and the connection between miR-101-3p and EZH2.Keywords
This publication has 35 references indexed in Scilit:
- Effect of the interaction between MiR‐200b‐3p and DNMT3A on cartilage cells of osteoarthritis patientsJournal of Cellular and Molecular Medicine, 2017
- Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancerAutophagy, 2017
- Endometrial cancerThe Lancet, 2016
- MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cellsOncotarget, 2014
- Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesisBiochemistry and Cell Biology, 2014
- Type I and II Endometrial Cancers: Have They Different Risk Factors?Journal of Clinical Oncology, 2013
- The microcosmos of cancerNature, 2012
- MicroRNA‐34b functions as a potential tumor suppressor in endometrial serous adenocarcinomaInternational Journal of Cancer, 2011
- Adjuvant Chemotherapy for Endometrial CancerInternational Journal of Gynecological Cancer, 2011
- Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomasCancer Science, 2009